Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Top Cited Papers
Open Access
- 1 May 2008
- Vol. 28 (5), 687-697
- https://doi.org/10.1016/j.immuni.2008.03.016
Abstract
No abstract availableKeywords
Funding Information
- Canadian Diabetes Association
- Canadian Institutes of Health Research
- National Institutes of Health
- Howard Hughes Medical Institute
- Juvenile Diabetes Research Foundation Australia
This publication has 63 references indexed in Scilit:
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunityNature Genetics, 2007
- Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signalsThe Journal of Experimental Medicine, 2007
- Clearance of apoptotic and necrotic cells and its immunological consequencesApoptosis, 2006
- Regulatory T‐cell physiology and application to treat autoimmunityImmunological Reviews, 2006
- Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigenThe Journal of Experimental Medicine, 2005
- THE NOD MOUSE: A Model of Immune DysregulationAnnual Review of Immunology, 2005
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- BCG Vaccination Prevents Insulin-Dependent Diabetes Mellitus (IDDM) in NOD Mice after Disease Acceleration with CyclophosphamideJournal of Autoimmunity, 1997
- Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐ToleranceImmunological Reviews, 1995